The new figure is C$25 million higher than the Canadian miner's previous plan of raising C$100 million. Collective will now issue 6.6 million shares at C$19.00 apiece, up from a previous 5.27 million ...
October gets a bum rap as a volatile month for markets, Mizuho's Steve Ricchiuto noted in commentary shared with MarketWatch on Thursday. While the S&P 500 has returned 0.5% on average during October ...
He’s used to giving me the silent treatment whenever there is conflict and he’s improved, but there is still a huge divide ...
Amgen's late-stage study of human monoclonal antibody Repatha hit its dual primary targets, demonstrating it significantly reduced the risk of major adverse cardiovascular events in individuals ...
Some investors look for stocks that have high dividend yields because they want the dividend income right now. But a strategy ...
As chief executive of Empower, Ed Murphy is responsible for the retirement savings of nearly 20 million American workers — ...
Gold was rising Thursday morning as the U.S. government shutdown continued, with the yellow metal extending a rally that ...
Shares of Tesla advanced after global vehicle deliveries in the third quarter rose 7.4% from a year ago, marking a reversal from steep declines that have mired the electric-vehicle maker this year.
Shares of Kodiak AI rose after Soros Fund Management disclosed a 5.7% passive stake in the autonomous truck developer. Its stock rose 8.9% to $5.96 in premarket trading Thursday. The Securities and ...
Warren Buffett’s Berkshire Hathaway says it is acquiring a “robust portfolio of operating assets,” in Occidental’s OxyChem.
Taysha Gene Therapies' investigational treatment for Rett syndrome has received breakthrough-therapy designation from the Food and Drug Administration.
This browser is no longer supported at MarketWatch. For the best MarketWatch.com experience, please update to a modern browser.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback